Anmelden/Registrieren
Erscheinungsjahr:
 
Zurück zur geteilten Ansicht
J. B. Vermorken

Veröffentlichungen von J. B. Vermorken zu Vermorken, J.B. ->
weitere Veröffentlichungen von J. B. Vermorken:
Pneumonectomy for Lung Metastases: [nl]Report of Ten Cases (2003)
Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: A multivariate analysis of 704 patients (1997)
The Role of Anthracyclines in Epithelial Ovarian Cancer (1999)
Growth and differentiation of human keratinocytes cultured on eye lens capsules (1985)
Randomised Trials in Ovarian Cancer: Trial Design Considerations (1999)
Analysis and pharmacokinetics of a new prodrug N-l-leucyldoxorubicin and its metabolises in plasma using HPLC with fluorescence detection (1992)
Human pharmacokinetics of carboplatin after oral administration (1989)
A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin (2000)
Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient (1996)
The ESMO programme of certification and training for medical oncology (1998)
Cytomegalovirus colitis after administration of docetaxel–5-fluorouracil–cisplatin chemotherapy for locally advanced hypopharyngeal cancer (1999)
Determination of the Antimetabolite Gemcitabine (2',2'-Difluoro-2'-deoxycytidine) and of 2',2'-Difluoro-2'-deoxyuridine by ^1^9F Nuclear Magnetic Resonance Spectroscopy (1993)
Proriatic hair follicle cells (1986)
Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy (1998)
Daily cis-dichlorodiammineplatinum (II) as a radio-enhancer: A preliminary toxicity report (1983)
Veröffentlichungen zu Vermorken, J.B.
Zurück zur geteilten Ansicht
Verfasser Titel Jahr absteigend sortierenaufsteigend sortieren
zeige Details
1
Eisenhauer, E. A., Vermorken, J. B., ... Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: A multivariate analysis of 704 patients
in: Annals of oncology , ISSN 1569-8041, Vol. 8 (10. 1997), p. 963-968
Zugang: zum Volltext
ähnliche Vorschläge
1997
zeige Details
2
Vermorken, J. B., Harper, P. G., ... The Role of Anthracyclines in Epithelial Ovarian Cancer
in: Annals of oncology , ISSN 1569-8041, Vol. 10 (1. 1999), p. 43-50
Zugang: zum Volltext
ähnliche Vorschläge
1999
zeige Details
3
Hendriks, J. M. H.. Pneumonectomy for Lung Metastases: [nl]Report of Ten Cases
In: The thoracic and cardiovascular surgeon. - Stuttgart : Thieme Vol. 51, No. 01 (2. 2003), p. 38-41
Zugang: zum Volltext
ähnliche Vorschläge
2003
zeige Details
4
Korst, A. E. C., Gall, Helen E., ... Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 39 (1/2. 1996), p. 162-166
Zugang: zum Volltext
ähnliche Vorschläge
1996
zeige Details
5
Wagener, D. J. Th., Vermorken, J. B., ... The ESMO programme of certification and training for medical oncology
in: Annals of oncology , ISSN 1569-8041, Vol. 9 (6. 1998), p. 585-587
Zugang: zum Volltext
ähnliche Vorschläge
1998
zeige Details
6
Brady, M. F., Thigpen, J. T., ... Randomised Trials in Ovarian Cancer: Trial Design Considerations
in: Annals of oncology , ISSN 1569-8041, Vol. 10 (1. 1999), p. 75-82
Zugang: zum Volltext
ähnliche Vorschläge
1999
zeige Details
7
Van den Brande, J., Schrijvers, D., ... Cytomegalovirus colitis after administration of docetaxel–5-fluorouracil–cisplatin chemotherapy for locally advanced hypopharyngeal cancer
in: Annals of oncology , ISSN 1569-8041, Vol. 10 (11. 1999), p. 1369-1372
Zugang: zum Volltext
ähnliche Vorschläge
1999
zeige Details
8
Vermorken, J. B., Kobierska, A., ... A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin
in: Annals of oncology , ISSN 1569-8041, Vol. 11 (8. 2000), p. 1035-1040
Zugang: zum Volltext
ähnliche Vorschläge
2000
zeige Details
9
De Jong, J., Vermorken, J.B., ... Analysis and pharmacokinetics of a new prodrug N-l-leucyldoxorubicin and its metabolises in plasma using HPLC with fluorescence detection
in: Journal of Pharmaceutical and Biomedical Analysis, in: Journal of Pharmaceutical and Biomedical Analysis . - Amsterdam : Elsevier, ISSN 0731-7085, ZDB-ID 1491820-1 Vol. 10, No. 4 (1992), p. 309-314
Zugang: zum Volltext
ähnliche Vorschläge
1992
zeige Details
10
Edzes, H.T., Peters, G.J., ... Determination of the Antimetabolite Gemcitabine (2',2'-Difluoro-2'-deoxycytidine) and of 2',2'-Difluoro-2'-deoxyuridine by ^1^9F Nuclear Magnetic Resonance Spectroscopy
in: Analytical Biochemistry, in: Analytical Biochemistry . - Amsterdam : Elsevier, ISSN 0003-2697, ZDB-ID 1461105-3 Vol. 214, No. 1 (1993), p. 25-30
Zugang: zum Volltext
ähnliche Vorschläge
1993
zeige Details
11
Boer, H. H., Moorer-van Delft, Carry M., ... Ultrastructural neuropathologic effects of Taxol on neurons of the freshwater snailLymnaea stagnalis
in: Journal of neuro-oncology , ISSN 1573-7373, Vol. 25 (1. 1995), p. 49-57
Zugang: zum Volltext
ähnliche Vorschläge
1995
zeige Details
12
van Rijswijk, R. E. N., Hoekman, K., ... Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or...
in: Annals of oncology , ISSN 1569-8041, Vol. 8 (12. 1997), p. 1235-1241
Zugang: zum Volltext
ähnliche Vorschläge
1997
zeige Details
13
Postma, T. J., Heimans, J. J., ... Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy
in: Annals of oncology , ISSN 1569-8041, Vol. 9 (7. 1998), p. 739-744
Zugang: zum Volltext
ähnliche Vorschläge
1998
zeige Details
14
Pinedo, H. M., Karim, A. B. M. F., ... Daily cis-dichlorodiammineplatinum (II) as a radio-enhancer: A preliminary toxicity report
in: Journal of cancer research and clinical oncology , ISSN 1432-1335, Vol. 105 (1. 1983), p. 79-82
Zugang: zum Volltext
ähnliche Vorschläge
1983
zeige Details
15
Mulder, P. H. M., Cappelaere, P., ... A phase II study of pirarubicin in patients with advanced recurrent head and neck squamous cell carcinoma
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 33 (5. 1994), p. 438-440
Zugang: zum Volltext
ähnliche Vorschläge
1994
zeige Details
16
Mulder, P. H. M. De, Cappelaere, P., ... A phase II study of pirarubicin in patients with advanced recurrent head and neck squamous cell carcinoma
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 33 (5. 1994), p. 438-440
Zugang: zum Volltext
ähnliche Vorschläge
1994
zeige Details
17
Postma, T.J., Hoekman, K., ... Peripheral Neuropathy Due to Biweekly Paclitaxel, Epirubicin and Cisplatin in Patients with Advanced Ovarian Cancer
in: Journal of neuro-oncology , ISSN 1573-7373, Vol. 45 (3. 1999), p. 241-246
Zugang: zum Volltext
ähnliche Vorschläge
1999
zeige Details
18
Planting, A. S. T., Catimel, G., ... Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer
in: Annals of oncology , ISSN 1569-8041, Vol. 10 (6. 1999), p. 693-700
Zugang: zum Volltext
ähnliche Vorschläge
1999
zeige Details
19
Kroep, J. R., Peters, G. J., ... Gemcitabine–cisplatin: A schedule finding study
in: Annals of oncology , ISSN 1569-8041, Vol. 10 (12. 1999), p. 1503-1510
Zugang: zum Volltext
ähnliche Vorschläge
1999
zeige Details
20
Veenhof, C.H.N., van der Burg, M.E.L., ... 8 High-dose megestrol acetate in advanced ovarian cancer: A phase II study
in: Journal of Steroid Biochemistry, in: Journal of Steroid Biochemistry . - Amsterdam : Elsevier, ISSN 0022-4731, ZDB-ID 2198730-0 Vol. 28 (1987), p. 215
Zugang: zum Volltext
ähnliche Vorschläge
1987